Previous 10 | Next 10 |
InvestorPlace - Stock Market News, Stock Advice & Trading Tips It’s been a few months since I last wrote about the best penny stocks . It’s never an easy task finding quality companies with rock-bottom prices under $5. In the past, I’ve limited my search...
LAKE FOREST, Ill., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. ("Assertio" or the "Company") (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that Dan Peisert, CEO, and Paul Schwichtenberg, CFO, will host investor meeti...
Summary Assertio Holdings, Inc. got the rights to Sympazan in October. Most Medicare plans cover it. Meanwhile, Assertio Holdings, Inc.'s lead product Indocin is a favored brand by the nation's #1 health insurance company. Assertio Holdings, Inc. ( ASRT ), is a small (...
Summary Assertio Holdings stock has shown phenomenal growth throughout 2022 - especially when compared to the S&P 500 Index and the Healthcare sector. After taking a closer look at this company, I conclude that its low valuation multiples are not just a temporary/cyclical phenomenon...
SYMPAZAN ® (clobazam) oral film from Assertio is used for the adjunctive treatment of seizures associated with LGS in patients two years of age and older Oral film delivery from SYMPAZAN ® delivers clobazam to LGS patients with no crushing, no mixing, no prep w...
LAKE FOREST, Ill., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that U.S. Patent, No. 11541002 for Sympazan®...
Summary Assertio Holdings is a pharmaceutical company based on a niche model that is focused on digital, non-personal promotion. Last Q3 showed great revenue and cash flow growth. The company's growth strategy is based on market acquisitions. The share price valuation seems to b...
Thanks to the stock market selling off this year, there are plenty of new penny stocks to watch. With that has also come a higher level of short selling to capitalize on the moves lower. But that is what some retail traders are betting on if and when the market turns around. The idea of a short s...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Irrespective of the stock market’s overall performance in the coming year, there are many stocks that could nonetheless “crush it” in 2023. Included in that category are some of the hottest penny stocks out...
LAKE FOREST, Ill., Dec. 13, 2022 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (NASDAQ: ASRT), a specialty pharmaceutical company offering differentiated products to patients, today announced that its executive team will host one-on-one inve...
News, Short Squeeze, Breakout and More Instantly...
Assertio Therapeutics Inc. Company Name:
ASRT Stock Symbol:
NASDAQ Market:
Assertio Therapeutics Inc. Website:
LAKE FOREST, Ill., July 24, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, today announced that it will rel...
2024-07-03 07:15:03 ET H.C. Wainwright analyst issues BUY recommendation for ASRT on July 3, 2024 06:04AM ET. ASRT was trading at $1.15 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy recommendati...
LAKE FOREST, Ill., June 05, 2024 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products to patients, announced that Ajay Patel, Chief...